8 March 2024 – To mark Internal Women’s Day, HMHB released its first Knowledge Byte of the year. Featured experts John Hoddinott and Bjørn Lomborg, authors of the 2023 Copenhagen Consensus Center Report, explain why multiple micronutrient supplements (MMS) for pregnant women are one of the most cost-effective interventions in the world for global development, offering a remarkable 37:1 return on investment.
WATCH THE KNOWLEDGE BYTE: INVEST IN THE BEST
The UNIMMAP MMS (United Nations International Multiple Micronutrient Antenatal Preparation Multiple Micronutrient Supplements) contains 15 essential vitamins, which are required during pregnancy for the health of the mother and the growth and development of the baby. Taking MMS during pregnancy reduces the risk of stillbirths, low birth weight, premature births, and small-for-gestational-age births, thus providing significant health benefits for mothers and their newborns.
The current standard of care in antenatal platforms includes iron-folic acid supplements (IFAS). The experts emphasize that transitioning to MMS from IFAS can lead to better pregnancy outcomes and higher economic returns.
